← Eichor
Condition: Autoimmune Encephalitis Ae Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Autoimmune Encephalitis Ae

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Media
Phase 1 · 1 location(s) · Tongji Hospital · NCT07526493Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?
Phase 2 · 1 location(s) · University Hospital, Toulouse · NCT07488117CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Tongji Hospital · NCT07337785
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.